SBT777101 for Rheumatoid Arthritis
(Regulate-RA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This study will test the safety and effects of SBT777101 when given as a single dose to subjects with rheumatoid arthritis. It is the first study of this treatment being done in humans. Increasing dose levels will be given after the safety at lower dose levels is shown.
Will I have to stop taking my current medications?
The trial requires that participants have stable doses of their rheumatoid arthritis medications for at least 30 days before joining, so you won't need to stop taking your current medications.
How does the drug SBT777101 differ from other rheumatoid arthritis treatments?
The drug SBT777101 is unique because it may target different pathways or mechanisms compared to existing treatments like TNF inhibitors and other biologic agents. While specific details about SBT777101 are not provided, it could offer a novel approach for patients who do not respond well to current therapies.12345
Who Is on the Research Team?
Joseph Arron, MD
Principal Investigator
Sonoma Biotherapeutics, Inc.
Are You a Good Fit for This Trial?
This trial is for adults with moderate-to-severe rheumatoid arthritis who haven't responded well to existing treatments. Participants must have a BMI under 35, at least one joint suitable for biopsy, and evidence of inflammation. They should be on stable RA medication doses for 30 days and use effective contraception. Excluded are those with recent major surgery, uncontrolled diseases in various organs, frequent infections or active tuberculosis, and other inflammatory joint diseases.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a single ascending dose of SBT777101 to evaluate safety and effects
DLT Evaluation
Participants are monitored for dose-limiting toxicities and other adverse effects
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- SBT777101
Find a Clinic Near You
Who Is Running the Clinical Trial?
Sonoma Biotherapeutics, Inc.
Lead Sponsor